After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $210.00. The ...

A Delaware jury has ruled in favor of Apple Inc. (NASDAQ:AAPL) in a patent infringement case against Masimo Corp. (NASDAQ ...

The protracted legal wrangling between Apple and health wearable company Masimo has resulted in a nominal ... focusing on the use of pulse oximetry sensors in some Apple Watches, which resulted ...

Needham analyst Michael Matson has maintained their neutral stance on MASI stock, giving a Hold rating on January 17.Invest with Confidence: ...